Research shows potential targeted therapy for metastatic breast cancer

the ONA take:

The drug enobosarm, administered daily, shows promise in tests for women with metastatic, androgen receptor positive, estrogen receptor positive breast cancer. Because the drug is tissue=specific, many of the side effects associated with endocrine therapy were not seen. The benefits of enobosarm treatment for other cancer types is also being evaluated.

Research shows potential targeted therapy for metastatic breast cancer
Research shows potential targeted therapy for metastatic breast cancer
Results from an open label clinical study, evaluating an oral daily dose of the drug enobosarm, shows promise for women with metastatic, androgen receptor positive, estrogen receptor positive breast cancer.  The new data is from a phase 2 study reported on Monday, June 2, 2014 at the meeting in Chicago of the American Society of Clinical Oncology (ASCO).
READ FULL ARTICLE From 170.223.191.243
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs